HomeCompareINVO vs NNN

INVO vs NNN: Dividend Comparison 2026

INVO yields 240.10% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INVO wins by $357.70M in total portfolio value
10 years
INVO
INVO
● Live price
240.10%
Share price
$0.83
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$357.72M
Annual income
$196,624,039.87
Full INVO calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — INVO vs NNN

📍 INVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINVONNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INVO + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INVO pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INVO
Annual income on $10K today (after 15% tax)
$20,408.16/yr
After 10yr DRIP, annual income (after tax)
$167,130,433.89/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, INVO beats the other by $167,128,204.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INVO + NNN for your $10,000?

INVO: 50%NNN: 50%
100% NNN50/50100% INVO
Portfolio after 10yr
$178.87M
Annual income
$98,313,331.27/yr
Blended yield
54.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

INVO
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
-12.7
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INVO buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINVONNN
Forward yield240.10%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$357.72M$25.5K
Annual income after 10y$196,624,039.87$2,622.67
Total dividends collected$340.27M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: INVO vs NNN ($10,000, DRIP)

YearINVO PortfolioINVO Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$34,710$24,009.60$10,735$614.96+$24.0KINVO
2$115,024$77,884.47$11,572$708.43+$103.5KINVO
3$364,291$241,215.35$12,531$819.53+$351.8KINVO
4$1,103,764$713,973.05$13,633$952.29+$1.09MINVO
5$3,202,772$2,021,744.06$14,909$1,111.84+$3.19MINVO
6$8,909,636$5,482,669.81$16,392$1,304.77+$8.89MINVO
7$23,787,491$14,254,180.96$18,129$1,539.52+$23.77MINVO
8$61,019,612$35,566,996.13$20,173$1,827.08+$61.00MINVO
9$150,558,618$85,267,633.75$22,597$2,181.81+$150.54MINVO
10$357,721,761$196,624,039.87$25,491$2,622.67+$357.70MINVO

INVO vs NNN: Complete Analysis 2026

INVOStock

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Full INVO Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this INVO vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INVO vs SCHDINVO vs JEPIINVO vs OINVO vs KOINVO vs MAININVO vs ADCINVO vs EPRTINVO vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.